Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 1;7(2):1051-1056.
doi: 10.1039/c5sc03471j. Epub 2015 Oct 28.

A highly selective near-infrared fluorescent probe for imaging H2Se in living cells and in vivo

Affiliations

A highly selective near-infrared fluorescent probe for imaging H2Se in living cells and in vivo

Fanpeng Kong et al. Chem Sci. .

Abstract

Hydrogen selenide (H2Se), a highly reactive Se species, is an important selenium metabolism intermediate involved in many physiological and pathological processes. This compound is of scientific interest with regard to the real-time monitoring of H2Se in living cells and in vivo to understand the anti-cancer mechanism of selenium. However, monitoring H2Se in living cells is still challenging due to the lack of straight forward, highly selective and rapid methods. Here, we developed a novel small-molecule fluorescent probe, NIR-H2Se, for imaging endogenous H2Se. NIR-H2Se exhibited high selectivity toward H2Se over selenocysteine (Sec), H2S and small molecule thiols and was successfully used to image the H2Se content in HepG2 cells during Na2SeO3-induced apoptosis. Increased H2Se content and reduced ROS levels were observed under hypoxic conditions compared to normoxic conditions, which indicated that the cell apoptosis induced by Na2SeO3 under a hypoxic environment is via a non-oxidative stress mechanism. Thus, this probe should serve as a powerful tool for exploring the physiological function of H2Se and Se anticancer mechanisms in a variety of physiological and pathological contexts.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1. Synthesis of NIR-H2Se. Reaction conditions: (a) NaH, DMF, rt, 73%; (b) SnCl2, HCl, CH3OH, 70 °C, 45%; (c) SeO2, grind, 71%.
Scheme 2
Scheme 2. Proposed mechanism for the selective reaction of H2Se.
Fig. 1
Fig. 1. (a) Fluorescence response of 10 μM NIR-H2Se to differing amounts of H2Se. (b) Linear correlation between the emission intensity and H2Se concentration. All spectra were acquired in 10 mM PBS with a pH of 7.4 (λ ex/λ em = 688/735 nm). The data were expressed as the mean ± standard deviation (SD) across three experiments.
Fig. 2
Fig. 2. (a) Fluorescence intensity changes for NIR-H2Se (10 μM) after adding 100 equiv. of thiols, Na2S, Na2SeO3, Sec, NAC, TrxR, Vc, various biologically related ROS and 10 equiv. of NO. The black bars show the addition of one of these interferents to a 10 μM NIR-H2Se solution. The red bars represent the addition of both H2Se and one interferent to the probe solution. (b) Time course for the fluorescence intensity of 10 μM NIR-H2Se with 10 μM H2Se in a 10 mM PBS, pH = 7.4, at room temperature.
Fig. 3
Fig. 3. Confocal fluorescence imaging of endogenous H2Se in HepG2 cells treated with sodium selenite under normoxic (20% pO2) and hypoxic (1% pO2) conditions. (a) The fluorescence changes for the HepG2 cells exposed to different sodium selenite concentrations (2–10 μM) for 12 h and incubated with NIR-H2Se (10 μM). (b) The fluorescence changes of the HepG2 cells exposed to 5 μM of sodium selenite for different times (0–12 h) and incubated with NIR-H2Se (10 μM). The fluorescence was imaged using a confocal microscope with 633 nm excitation and 650–750 nm collection. (c) The fluorescence intensity for (a). (d) The fluorescence intensity for (b). The data were normalized to the control, and statistical analyses were performed using a two-tailed Student's t-test (n ≥ 4 fields of cells) relative to the control. *P < 0.01 and the error bars are ± the standard error measurement.
Fig. 4
Fig. 4. Confocal fluorescence imaging of H2O2 in HepG2 cells treated with sodium selenite under normoxic (20% pO2) and hypoxic (1% pO2) environments. (a) The fluorescence changes in the HepG2 cells exposed to different sodium selenite concentrations (2–10 μM) for 12 h and incubated with a H2O2 probe (10 μM). (b) The fluorescence changes for the HepG2 cells exposed to a 5 μM sodium selenite solution for different times (0–12 h) and incubated with a H2O2 probe (10 μM). The fluorescence was imaged using a confocal microscope with 532 nm excitation and 600–700 nm collection. (c) The fluorescence intensity for (a). (d) The fluorescence intensity for (b). The data were normalized to the control, and statistical analyses were performed using a two-tailed Student's t-test (n ≥ 4 fields of cells) relative to the control. *P < 0.01 and the error bars are ± the standard error measurement.
Fig. 5
Fig. 5. (a) In vivo fluorescence imaging of H22 tumor-bearing mice injected with the probe NIR-H2Se (10 μM) in response to sodium selenite (10 μM) at different times. (b) The fluorescence intensity for (a). The data were normalized to the control.

Similar articles

Cited by

References

    1. Weekley C. M., Harris H. H. Chem. Soc. Rev. 2013;42:8870–8894. - PubMed
    2. Rayman M. P. Lancet. 2012;379:1256–1268. - PubMed
    1. Reeves M. A., Hoffmann P. R. Cell. Mol. Life Sci. 2009;66:2457–2478. - PMC - PubMed
    2. Misra S., Peak D., Chen N., Hamilton C., Niyogi S. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 2012;155:560–565. - PubMed
    3. Fairweather-Tait S. J., Bao Y., Broadley M. R., Collings R., Ford D., Hesketh J. E., Hurst R. Antioxid. Redox Signaling. 2011;14:1337–1383. - PubMed
    1. Weekley C. M., Aitken J. B., Vogt S., Finney L. A., Paterson D. J., de Jonge M. D., Howard D. L., Musgrave I. F., Harris H. H. Biochemistry. 2011;50:1641–1650. - PubMed
    2. Duffield-Lillico A. J., Reid M. E., Turnbull B. W., Combs Jr G. F., Slate E. H., Fischbach L. A., Marshall J. R., Clark L. C. Cancer Epidemiol., Biomarkers Prev. 2002;11:630–639. - PubMed
    3. Weekley C. M., Aitken J. B., Vogt S., Finney L. A., Paterson D. J., de Jonge M. D., Howard D. L., Witting P. K., Musgrave I. F., Harris H. H. J. Am. Chem. Soc. 2011;133:18272–18279. - PMC - PubMed
    1. Weekley C. M., Harris H. H. Chem. Soc. Rev. 2013;42:8870–8894. - PubMed
    2. Clark L. C., Combs G. F., Turnbull B. W., Slate E. H., Chalker D. K., Chow J., Davis L. S., Glover R. A., Graham G. F., Gross E. G. J. Am. Med. Assoc. 1996;276:1957–1963. - PubMed
    3. Lipp-man S. M., Klein E. A., Goodman P. J., Lucia M. S., Thompson I. M., Ford L. G., Parnes H. L., Minasian L. M., Gaziano J. M., Hartline J. A. J. Am. Med. Assoc. 2009;301:39–51. - PubMed
    1. Combs G., Gray W. Pharmacol. Ther. 1998;79:179–192. - PubMed

LinkOut - more resources